SG10202111790YA - Synthesis of omecamtiv mecarbil - Google Patents
Synthesis of omecamtiv mecarbilInfo
- Publication number
- SG10202111790YA SG10202111790YA SG10202111790YA SG10202111790YA SG10202111790YA SG 10202111790Y A SG10202111790Y A SG 10202111790YA SG 10202111790Y A SG10202111790Y A SG 10202111790YA SG 10202111790Y A SG10202111790Y A SG 10202111790YA SG 10202111790Y A SG10202111790Y A SG 10202111790YA
- Authority
- SG
- Singapore
- Prior art keywords
- synthesis
- omecamtiv mecarbil
- mecarbil
- omecamtiv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762527174P | 2017-06-30 | 2017-06-30 | |
US201862664363P | 2018-04-30 | 2018-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202111790YA true SG10202111790YA (en) | 2021-12-30 |
Family
ID=62976317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202111790YA SG10202111790YA (en) | 2017-06-30 | 2018-06-29 | Synthesis of omecamtiv mecarbil |
Country Status (27)
Country | Link |
---|---|
US (3) | US11040956B2 (hr) |
EP (3) | EP3925950B1 (hr) |
JP (2) | JP7181896B2 (hr) |
KR (1) | KR102625774B1 (hr) |
CN (1) | CN110799503B (hr) |
AU (1) | AU2018294254C1 (hr) |
BR (1) | BR112019028205A2 (hr) |
CA (1) | CA3063102A1 (hr) |
CL (2) | CL2019003898A1 (hr) |
CY (1) | CY1124427T1 (hr) |
DK (1) | DK3645518T3 (hr) |
ES (1) | ES2882905T3 (hr) |
GE (1) | GEP20227340B (hr) |
HR (1) | HRP20211290T1 (hr) |
HU (1) | HUE055242T2 (hr) |
IL (2) | IL270663B (hr) |
LT (1) | LT3645518T (hr) |
MD (1) | MD3645518T2 (hr) |
MX (2) | MX2021013326A (hr) |
PL (1) | PL3645518T3 (hr) |
PT (1) | PT3645518T (hr) |
RS (1) | RS62328B1 (hr) |
SG (1) | SG10202111790YA (hr) |
SI (1) | SI3645518T1 (hr) |
TW (2) | TW202235415A (hr) |
UA (1) | UA127517C2 (hr) |
WO (1) | WO2019006231A1 (hr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2970123T3 (pl) | 2013-03-14 | 2020-03-31 | Amgen Inc. | Sól omekamtywu mekarbilu i sposób otrzymywania soli |
WO2019006235A1 (en) | 2017-06-30 | 2019-01-03 | Amgen Inc. | METHODS OF TREATING CARDIAC INSUFFICIENCY WITH CARDIAC SARCOMER ACTIVATORS |
IL270663B (en) | 2017-06-30 | 2022-08-01 | Amgen Inc | Synthesis of omecamtib from carbyl |
AU2018332887B2 (en) | 2017-09-13 | 2022-12-08 | Amgen Inc. | Bisamide sarcomere activating compounds and uses thereof |
AU2019321573A1 (en) | 2018-08-17 | 2021-03-04 | Amgen Inc. | Salts and crystal forms of omecamtiv mecarbil |
WO2021070123A1 (en) * | 2019-10-09 | 2021-04-15 | Dr. Reddy’S Laboratories Limited | Solid forms of omecamtiv mecarbil dihydrochloride and processes thereof |
US20220411374A1 (en) * | 2019-10-09 | 2022-12-29 | Dr. Reddy's Laboratories Limited | Alternate processes for the preparation of omecamtiv mecarbil |
BR112023018095A2 (pt) | 2021-03-10 | 2023-12-12 | Amgen Inc | Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo |
WO2023205291A2 (en) * | 2022-04-21 | 2023-10-26 | The Board Of Regents Of The University Of Oklahoma | Targeting myocardial tissue for delivery of therapeutic and imaging agents |
US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6492529B1 (en) * | 2000-01-18 | 2002-12-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Bis pyrazole-1H-pyrazole intermediates and their synthesis |
BRPI0512193B8 (pt) | 2004-06-17 | 2021-05-25 | Cytokinetics Inc | composto ou sal farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou sal |
US20070208000A1 (en) | 2005-12-15 | 2007-09-06 | Morgan Bradley P | Certain chemical entities, compositions and methods |
TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
EP1962852B1 (en) * | 2005-12-19 | 2017-01-25 | Cytokinetics, Inc. | Compounds, compositions and methods |
GEP20125425B (en) * | 2006-10-18 | 2012-03-26 | Pfizer Prod Inc | Biaryl ether urea compounds |
US20090192168A1 (en) | 2008-01-04 | 2009-07-30 | Alex Muci | Compounds, Compositions and Methods |
WO2010141817A1 (en) * | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
ES2733340T3 (es) | 2013-03-14 | 2019-11-28 | Amgen Inc | Compuestos heterocíclicos y sus usos |
PL2970123T3 (pl) * | 2013-03-14 | 2020-03-31 | Amgen Inc. | Sól omekamtywu mekarbilu i sposób otrzymywania soli |
CN106163585B (zh) | 2014-03-31 | 2019-07-16 | 株式会社美迪克 | 血液净化装置及血液净化装置的启动加注方法 |
ES2713700T3 (es) * | 2014-11-24 | 2019-05-23 | Medifron Dbt Inc | Derivados de carboxamida y urea a base de oxazol y tiazol sustituidos como ligandos del receptor de vainilloide II |
WO2016123291A1 (en) | 2015-01-29 | 2016-08-04 | Signal Pharmaceuticals, Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
US10543215B2 (en) | 2015-06-26 | 2020-01-28 | Amgen Inc. | Combination therapy of cardiac myosin activator and sinus node if current inhibitor |
WO2019006235A1 (en) | 2017-06-30 | 2019-01-03 | Amgen Inc. | METHODS OF TREATING CARDIAC INSUFFICIENCY WITH CARDIAC SARCOMER ACTIVATORS |
IL270663B (en) | 2017-06-30 | 2022-08-01 | Amgen Inc | Synthesis of omecamtib from carbyl |
HUE052049T2 (hu) | 2018-07-09 | 2021-04-28 | Fis Fabbrica Italiana Sintetici Spa | Kristályos 2-fluor-3-nitrotoluol és eljárás annak elõállítására |
AU2019321573A1 (en) | 2018-08-17 | 2021-03-04 | Amgen Inc. | Salts and crystal forms of omecamtiv mecarbil |
US20220042055A1 (en) | 2018-12-18 | 2022-02-10 | Amgen Inc. | Method of reducing aromatic nitro compounds |
US20220411374A1 (en) | 2019-10-09 | 2022-12-29 | Dr. Reddy's Laboratories Limited | Alternate processes for the preparation of omecamtiv mecarbil |
BR112022015457A2 (pt) | 2020-02-10 | 2022-10-04 | Amgen Inc | Formulação de comprimido, método para tratar insuficiência cardíaca, uso de uma formulação de comprimido, e, processo para fazer uma formulação de comprimido |
EP4243825A1 (en) | 2020-11-12 | 2023-09-20 | Amgen Inc. | Methods of treating heart failure by administering omecamtiv mecarbil |
BR112023018095A2 (pt) | 2021-03-10 | 2023-12-12 | Amgen Inc | Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo |
-
2018
- 2018-06-29 IL IL270663A patent/IL270663B/en unknown
- 2018-06-29 TW TW111120441A patent/TW202235415A/zh unknown
- 2018-06-29 LT LTEP18743314.9T patent/LT3645518T/lt unknown
- 2018-06-29 KR KR1020207001578A patent/KR102625774B1/ko active IP Right Grant
- 2018-06-29 SI SI201830350T patent/SI3645518T1/sl unknown
- 2018-06-29 US US16/607,940 patent/US11040956B2/en active Active
- 2018-06-29 ES ES18743314T patent/ES2882905T3/es active Active
- 2018-06-29 MX MX2021013326A patent/MX2021013326A/es unknown
- 2018-06-29 GE GEAP201815258A patent/GEP20227340B/en unknown
- 2018-06-29 HU HUE18743314A patent/HUE055242T2/hu unknown
- 2018-06-29 SG SG10202111790YA patent/SG10202111790YA/en unknown
- 2018-06-29 EP EP21174262.2A patent/EP3925950B1/en active Active
- 2018-06-29 AU AU2018294254A patent/AU2018294254C1/en active Active
- 2018-06-29 RS RS20210965A patent/RS62328B1/sr unknown
- 2018-06-29 DK DK18743314.9T patent/DK3645518T3/da active
- 2018-06-29 MX MX2021009594A patent/MX2021009594A/es unknown
- 2018-06-29 IL IL294834A patent/IL294834A/en unknown
- 2018-06-29 BR BR112019028205-0A patent/BR112019028205A2/pt unknown
- 2018-06-29 PT PT187433149T patent/PT3645518T/pt unknown
- 2018-06-29 MD MDE20200486T patent/MD3645518T2/ro unknown
- 2018-06-29 EP EP18743314.9A patent/EP3645518B1/en active Active
- 2018-06-29 CN CN201880043674.6A patent/CN110799503B/zh active Active
- 2018-06-29 WO PCT/US2018/040176 patent/WO2019006231A1/en active Application Filing
- 2018-06-29 UA UAA202000509A patent/UA127517C2/uk unknown
- 2018-06-29 PL PL18743314T patent/PL3645518T3/pl unknown
- 2018-06-29 CA CA3063102A patent/CA3063102A1/en active Pending
- 2018-06-29 JP JP2019561794A patent/JP7181896B2/ja active Active
- 2018-06-29 EP EP23189293.6A patent/EP4265597A3/en active Pending
- 2018-06-29 TW TW107122465A patent/TWI769272B/zh active
-
2019
- 2019-12-30 CL CL2019003898A patent/CL2019003898A1/es unknown
-
2021
- 2021-05-19 US US17/324,867 patent/US11753394B2/en active Active
- 2021-08-10 CY CY20211100714T patent/CY1124427T1/el unknown
- 2021-08-11 HR HRP20211290TT patent/HRP20211290T1/hr unknown
- 2021-08-16 CL CL2021002167A patent/CL2021002167A1/es unknown
-
2022
- 2022-08-19 JP JP2022130911A patent/JP2022166243A/ja active Pending
-
2023
- 2023-07-26 US US18/359,467 patent/US20230373955A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273230A (en) | Preparation of carbamoylpyridone-polycyclic compounds | |
ZA201808057B (en) | Synthesis of indazoles | |
SG10202111790YA (en) | Synthesis of omecamtiv mecarbil | |
IL295588A (en) | Synthesis of the Lichondrins | |
IL262413B (en) | Synthesis of indazoles | |
EP3500286A4 (en) | N-CARBOXYANHYDRIDE-BASED ELAMIPRETIDE SCALE SYNTHESIS | |
HK1250719A1 (zh) | 脫氧糖胺的合成 | |
EP3612516C0 (en) | SYNTHESIS OF MESOTRIONE | |
IL273784A (en) | Synthesis of cantharidin | |
GB2544486B (en) | Synthesis of Ammonia | |
PL3752507T3 (pl) | Synteza triazolochinozalinonów | |
GB201807468D0 (en) | Methods of synthesis | |
GB201721386D0 (en) | Chrondogy of time-wave |